Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes

Melissa D. Gans, Tatyana Gavrilova

Research output: Contribution to journalReview article

Abstract

Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality, and financial burden worldwide. Asthma is now recognized as a heterogeneous disease and emerging clinical and laboratory research has elucidated understanding of asthma's underlying immunology. The future of asthma is classifying asthma by endotype through connecting discernible characteristics with immunological mechanisms. This comprehensive review of the immunology of asthma details the currently known pathophysiology and clinical practice biomarkers in addition to forefront biologic and targeted therapies for all of the asthma endotypes. By understanding the immunology of asthma, practitioners will be able to diagnose patients by asthma endotype and provide personalized, biomarker-driven treatments to effectively control patients’ asthma.

Original languageEnglish (US)
JournalPaediatric Respiratory Reviews
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Allergy and Immunology
Asthma
Biomarkers
Therapeutics
Biological Therapy
Pediatrics
Morbidity
Mortality

Keywords

  • Asthma
  • Biomarkers
  • Immunology
  • Pathophysiology
  • Phenotypes
  • Review

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

@article{eeff9a504ecf41f2b5125f9ef7224691,
title = "Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes",
abstract = "Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality, and financial burden worldwide. Asthma is now recognized as a heterogeneous disease and emerging clinical and laboratory research has elucidated understanding of asthma's underlying immunology. The future of asthma is classifying asthma by endotype through connecting discernible characteristics with immunological mechanisms. This comprehensive review of the immunology of asthma details the currently known pathophysiology and clinical practice biomarkers in addition to forefront biologic and targeted therapies for all of the asthma endotypes. By understanding the immunology of asthma, practitioners will be able to diagnose patients by asthma endotype and provide personalized, biomarker-driven treatments to effectively control patients’ asthma.",
keywords = "Asthma, Biomarkers, Immunology, Pathophysiology, Phenotypes, Review",
author = "Gans, {Melissa D.} and Tatyana Gavrilova",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.prrv.2019.08.002",
language = "English (US)",
journal = "Paediatric Respiratory Reviews",
issn = "1526-0550",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Understanding the immunology of asthma

T2 - Pathophysiology, biomarkers, and treatments for asthma endotypes

AU - Gans, Melissa D.

AU - Gavrilova, Tatyana

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality, and financial burden worldwide. Asthma is now recognized as a heterogeneous disease and emerging clinical and laboratory research has elucidated understanding of asthma's underlying immunology. The future of asthma is classifying asthma by endotype through connecting discernible characteristics with immunological mechanisms. This comprehensive review of the immunology of asthma details the currently known pathophysiology and clinical practice biomarkers in addition to forefront biologic and targeted therapies for all of the asthma endotypes. By understanding the immunology of asthma, practitioners will be able to diagnose patients by asthma endotype and provide personalized, biomarker-driven treatments to effectively control patients’ asthma.

AB - Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality, and financial burden worldwide. Asthma is now recognized as a heterogeneous disease and emerging clinical and laboratory research has elucidated understanding of asthma's underlying immunology. The future of asthma is classifying asthma by endotype through connecting discernible characteristics with immunological mechanisms. This comprehensive review of the immunology of asthma details the currently known pathophysiology and clinical practice biomarkers in addition to forefront biologic and targeted therapies for all of the asthma endotypes. By understanding the immunology of asthma, practitioners will be able to diagnose patients by asthma endotype and provide personalized, biomarker-driven treatments to effectively control patients’ asthma.

KW - Asthma

KW - Biomarkers

KW - Immunology

KW - Pathophysiology

KW - Phenotypes

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=85074484442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074484442&partnerID=8YFLogxK

U2 - 10.1016/j.prrv.2019.08.002

DO - 10.1016/j.prrv.2019.08.002

M3 - Review article

C2 - 31678040

AN - SCOPUS:85074484442

JO - Paediatric Respiratory Reviews

JF - Paediatric Respiratory Reviews

SN - 1526-0550

ER -